# A Trial to Evaluate Efficacy of Heart-protecting Musk Pill

> **NCT01897805** · PHASE4 · UNKNOWN · sponsor: **Shanghai Hutchison Pharmaceuticals Limited** · enrollment: 2700 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Heart-protecting Musk Pill
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01897805
- **Lead sponsor:** Shanghai Hutchison Pharmaceuticals Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2015-06
- **Final completion:** 2015-12
- **Target enrollment:** 2700 (ESTIMATED)
- **Last updated:** 2014-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01897805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01897805, "A Trial to Evaluate Efficacy of Heart-protecting Musk Pill". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01897805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
